As part of our Advocacy work, the CSPA often prepares submissions on consultations run by governments across Canada on important topics that affect skin patients.
CSPA Submissions to Policy Consultations
CSPA supported a joint submission to the federal government's rare disease drug strategy consultation in March 2021 asking the federal government to include cancers - and rare cancers, in particular - in the strategy.
The CSPA signed on to a joint letter from cancer patient organizations earlier this year regarding increases to the Canada Health Transfer. A copy of the letter was sent to the minister of health, deputy minister, and Chief Medical Officer or Chief Public Health Officer of each province